Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Journal of Oncology
|
May 22, 2013
Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
Nigel P Murray, Eduardo Reyes, Leonardo Badínez, et al.
Urologic Oncology
|
July 7, 2016
Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Oncology Reports
|
July 29, 2010
P504S expressing circulating prostate cells as a marker for prostate cancer
Nigel P Murray, Gloria M Calaf, Leonardo Badinez, et al.
Urology Journal
|
January 9, 2020
Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Ecancermedicalscience
|
July 9, 2019
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
International Journal of Molecular Sciences
|
March 13, 2025
Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea
Gabriel Aedo, Marco Chahuán, Elsa Gatica, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
November 25, 2019
Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Ecancermedicalscience
|
July 9, 2019
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
Nigel P Murray, Sócrates Aedo, Ricardo Villalon, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Journal of Oncology
|
May 22, 2013
Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
Nigel P Murray, Eduardo Reyes, Leonardo Badínez, et al.
Urologic Oncology
|
July 7, 2016
Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Oncology Reports
|
July 29, 2010
P504S expressing circulating prostate cells as a marker for prostate cancer
Nigel P Murray, Gloria M Calaf, Leonardo Badinez, et al.
Urology Journal
|
January 9, 2020
Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
Ecancermedicalscience
|
July 9, 2019
Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, et al.
International Journal of Molecular Sciences
|
March 13, 2025
Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea
Gabriel Aedo, Marco Chahuán, Elsa Gatica, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
November 25, 2019
Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
Nigel P Murray, Cynthia Fuentealba, Eduardo Reyes, et al.
Ecancermedicalscience
|
July 9, 2019
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
Nigel P Murray, Sócrates Aedo, Ricardo Villalon, et al.
Page
of 8